219 related articles for article (PubMed ID: 17394192)
1. The safety of breast-conserving therapy in patients with breast cancer aged < or = 40 years.
van der Leest M; Evers L; van der Sangen MJ; Poortmans PM; van de Poll-Franse LV; Vulto AJ; Nieuwenhuijzen GA; Brenninkmeijer SJ; Creemers GJ; Voogd AC
Cancer; 2007 May; 109(10):1957-64. PubMed ID: 17394192
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
[TBL] [Abstract][Full Text] [Related]
3. Improving local control with breast-conserving therapy: a 27-year single-institution experience.
Cabioglu N; Hunt KK; Buchholz TA; Mirza N; Singletary SE; Kuerer HM; Babiera GV; Ames FC; Sahin AA; Meric-Bernstam F
Cancer; 2005 Jul; 104(1):20-9. PubMed ID: 15912514
[TBL] [Abstract][Full Text] [Related]
4. Are breast conservation and mastectomy equally effective in the treatment of young women with early breast cancer? Long-term results of a population-based cohort of 1,451 patients aged ≤ 40 years.
van der Sangen MJ; van de Wiel FM; Poortmans PM; Tjan-Heijnen VC; Nieuwenhuijzen GA; Roumen RM; Ernst MF; Tutein Nolthenius-Puylaert MC; Voogd AC
Breast Cancer Res Treat; 2011 May; 127(1):207-15. PubMed ID: 20703938
[TBL] [Abstract][Full Text] [Related]
5. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases.
Komoike Y; Akiyama F; Iino Y; Ikeda T; Akashi-Tanaka S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H
Cancer; 2006 Jan; 106(1):35-41. PubMed ID: 16333848
[TBL] [Abstract][Full Text] [Related]
6. Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy.
Meric F; Mirza NQ; Vlastos G; Buchholz TA; Kuerer HM; Babiera GV; Singletary SE; Ross MI; Ames FC; Feig BW; Krishnamurthy S; Perkins GH; McNeese MD; Strom EA; Valero V; Hunt KK
Cancer; 2003 Feb; 97(4):926-33. PubMed ID: 12569592
[TBL] [Abstract][Full Text] [Related]
7. Long term results with breast-conserving therapy for patients with early stage breast carcinoma in a community hospital setting.
Kini VR; White JR; Horwitz EM; Dmuchowski CF; Martinez AA; Vicini FA
Cancer; 1998 Jan; 82(1):127-33. PubMed ID: 9428488
[TBL] [Abstract][Full Text] [Related]
8. Early-stage young breast cancer patients: impact of local treatment on survival.
Bantema-Joppe EJ; de Munck L; Visser O; Willemse PH; Langendijk JA; Siesling S; Maduro JH
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e553-9. PubMed ID: 21601378
[TBL] [Abstract][Full Text] [Related]
9. Profile of prognostic factors in 1022 Indian women with early-stage breast cancer treated with breast-conserving therapy.
Dinshaw KA; Budrukkar AN; Chinoy RF; Sarin R; Badwe R; Hawaldar R; Shrivastava SK
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1132-41. PubMed ID: 15978744
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes after breast conservation therapy for early stage breast cancer in a community setting.
McCloskey SA; Botnick LE; Rose CM; Malcolm AW; Ozohan ML; Mena R; Llamas L; Tao ML
Breast J; 2006; 12(2):138-44. PubMed ID: 16509838
[TBL] [Abstract][Full Text] [Related]
11. Survival and breast relapse in 3834 patients with T1-T2 breast cancer after conserving surgery and adjuvant treatment.
Livi L; Paiar F; Saieva C; Scoccianti S; Dicosmo D; Borghesi S; Agresti B; Nosi F; Orzalesi L; Santini R; Barca R; Biti GP
Radiother Oncol; 2007 Mar; 82(3):287-93. PubMed ID: 17188382
[TBL] [Abstract][Full Text] [Related]
12. Factors contributing to improved local control after mastectomy in patients with breast cancer aged 40 years or younger.
Lammers EJ; Huibers P; van der Sangen MJ; van de Poll-Franse LV; Poortmans PM; Ernst MF; Lemaire BM; Meijs CM; Nuytinck HK; Voogd AC
Breast; 2010 Feb; 19(1):44-9. PubMed ID: 19913419
[TBL] [Abstract][Full Text] [Related]
13. [Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence].
Fodor J
Magy Onkol; 2007; 51(2):127-31. PubMed ID: 17660868
[TBL] [Abstract][Full Text] [Related]
14. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial.
Poggi MM; Danforth DN; Sciuto LC; Smith SL; Steinberg SM; Liewehr DJ; Menard C; Lippman ME; Lichter AS; Altemus RM
Cancer; 2003 Aug; 98(4):697-702. PubMed ID: 12910512
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast.
Meijnen P; Oldenburg HS; Peterse JL; Bartelink H; Rutgers EJ
Ann Surg Oncol; 2008 Jan; 15(1):235-43. PubMed ID: 17987342
[TBL] [Abstract][Full Text] [Related]
16. Differences in patterns of failure in patients treated with accelerated partial breast irradiation versus whole-breast irradiation: a matched-pair analysis with 10-year follow-up.
Antonucci JV; Wallace M; Goldstein NS; Kestin L; Chen P; Benitez P; Dekhne N; Martinez A; Vicini F
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):447-52. PubMed ID: 19058921
[TBL] [Abstract][Full Text] [Related]
17. The prognosis of patients with local recurrence more than five years after breast conservation therapy for invasive breast carcinoma.
van der Sangen MJ; van de Poll-Franse LV; Roumen RM; Rutten HJ; Coebergh JW; Vreugdenhil G; Voogd AC
Eur J Surg Oncol; 2006 Feb; 32(1):34-8. PubMed ID: 16305821
[TBL] [Abstract][Full Text] [Related]
18. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.
Truong PT; Jones SO; Kader HA; Wai ES; Speers CH; Alexander AS; Olivotto IA
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):357-64. PubMed ID: 18676091
[TBL] [Abstract][Full Text] [Related]
19. [Recurrence and survival after breast-conserving treatment of breast cancer].
Mjaaland I; Segers RM; Dybvik KI; Bjerkeset O; Kvaløy JT; Heikkilä R
Tidsskr Nor Laegeforen; 2010 Feb; 130(4):370-4. PubMed ID: 20220860
[TBL] [Abstract][Full Text] [Related]
20. Safety and feasibility of breast conserving therapy in Indian women: two decades of experience at Tata Memorial Hospital.
Dinshaw KA; Sarin R; Budrukkar AN; Shrivastava SK; Deshpande DD; Chinoy RF; Badwe R; Hawaldar R
J Surg Oncol; 2006 Aug; 94(2):105-13. PubMed ID: 16847919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
